Alembic Pharma to announce half-year results November 4
Alembic Pharmaceuticals Limited is scheduled to hold a board of directors meeting on Tuesday, November 4, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025.
In compliance with the company's code of conduct, the trading window for designated persons and their immediate relatives, which was closed from October 1, 2025, will re-open 48 hours after the declaration of these financial results. The company has formally notified both BSE Limited and the National Stock Exchange of India Ltd. of this upcoming board meeting and the purpose of the deliberation.
The announcement was made on October 23, 2025, by Manisha Saraf, company secretary. The market will be closely watching for the release of these results to gauge the company's performance during the specified periods.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime